Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/11/2024 | $27.00 → $26.00 | Buy | TD Cowen |
| 10/17/2024 | $22.00 → $27.00 | Buy | TD Cowen |
| 8/12/2024 | $20.00 → $18.00 | Buy | TD Cowen |
| 8/18/2022 | $14.00 → $23.00 | Neutral → Buy | Goldman |
| 2/28/2022 | $23.00 → $20.00 | Outperform | Cowen |
| 2/28/2022 | $19.00 → $28.00 | Buy | HC Wainwright & Co. |
| 1/6/2022 | $23.00 | Neutral | Credit Suisse |
| 11/23/2021 | $30.00 | Peer Perform → Outperform | Wolfe Research |
SC 13G/A - Calumet Specialty Products Partners, L.P. (0001340122) (Subject)
SC 13G/A - Calumet Specialty Products Partners, L.P. (0001340122) (Subject)
SC 13G/A - Calumet Specialty Products Partners, L.P. (0001340122) (Subject)
INDIANAPOLIS, Aug. 3, 2022 /PRNewswire/ -- Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) ("Calumet", "the Partnership", "we", "us", "our") announced today the appointment of Karen Twitchell and John (Jack) Boss to the Board of Directors effective August 2, 2022. Concurrently, Calumet announced that Robert (Bob) Funk has elected to retire from the Board of Directors. "On behalf of everyone at Calumet, I'd like to thank Bob for his many years of service and significant contributions to the Partnership. We'll particularly miss his operational expertise, wisdom and commitment to the success of Calumet," said Steve Mawer, Executive Chairman. "When Bob notified us of his intent to reti
4 - Calumet Specialty Products Partners, L.P. (0001340122) (Issuer)
INDIANAPOLIS, Jan. 15, 2025 /PRNewswire/ -- Calumet, Inc. (NASDAQ:CLMT) (the "Company," "Calumet," "we," "our" or "us") provided an update on its recent financing activity, including the pricing by its wholly owned subsidiaries, Calumet Specialty Products Partners, L.P. (the "Partnership") and Calumet Finance Corp., of their private placement of $100 million in aggregate principal amount of 9.75% Senior Notes due 2028 (the "Notes Offering") and registration its $65 million at-the-market equity program (the "ATM Program"). "Yesterday's successful bond pricing was a targeted piece of refinancing," said Todd Borgmann, CEO. "In conjunction with the notes offering, Calumet registered a small AT
INDIANAPOLIS, Jan. 14, 2025 /PRNewswire/ -- Calumet, Inc. (NASDAQ:CLMT) (the "Company" or "Calumet") today announced that its wholly owned subsidiaries, Calumet Specialty Products Partners, L.P. (the "Partnership") and Calumet Finance Corp. (together with the Partnership, the "Issuers"), priced their private placement (the "Offering") under Rule 144A and Regulation S under the Securities Act of 1933, as amended (the "Securities Act"), of $100 million in aggregate principal amount of 9.75% Senior Notes due 2028 (the "New Notes"). The New Notes mature on July 15, 2028 and will be issued at 98% of par. The Offering is expected to close on January 16, 2025, subject to customary closing condition
INDIANAPOLIS, Jan. 14, 2025 /PRNewswire/ -- Calumet, Inc. (NASDAQ:CLMT) (the "Company" or "Calumet") today announced that, subject to market conditions, its wholly owned subsidiaries, Calumet Specialty Products Partners, L.P. (the "Partnership") and Calumet Finance Corp. (together with the Partnership, the "Issuers"), intend to offer (the "Offering") for sale to eligible purchasers in a private placement under Rule 144A and Regulation S under the Securities Act of 1933, as amended (the "Securities Act"), $100 million in aggregate principal amount of 9.75% Senior Notes due 2028 (the "New Notes"). Calumet intends to use all of the net proceeds from the Offering to redeem a portion of the Issue
INDIANAPOLIS, Jan. 10, 2025 /PRNewswire/ -- Calumet, Inc. (NASDAQ:CLMT) (the "Company," "Calumet," "we," "our" or "us"), announced today that it plans to hold an analysts call on January 13, 2025, at 9:00 a.m. ET to discuss the closing of its $1.44 billion guaranteed loan with the U.S. Department of Energy Loan Programs Office. Investors, analysts and members of the media interested in listening to the live presentation are encouraged to join a webcast of the call with accompanying presentation slides; parties interested in listening to the webcast may follow the link which will be made available at http://calumetspecialty.investorroom.com/events. For those participants wishing to dial i
Third quarter 2024 net loss of $100.6 million, or basic loss per common share of $1.18 per shareThird quarter 2024 Adjusted EBITDA of $49.8 millionMontana Renewables ("MRL") set another new SAF production volume recordSpecialties business posted highest production levels in over five yearsMontana Renewables announced conditional commitment of $1.44 billion Department of Energy ("DOE") loanSuccessfully completed conversion from a Master Limited Partnership ("MLP") to a C-CorpINDIANAPOLIS, Nov. 8, 2024 /PRNewswire/ -- Calumet, Inc. (NASDAQ:CLMT) today reported results of Calumet, Inc. (the "Company," "Calumet," "we," "our" or "us") for the third quarter ended September 30, 2024, as follows: T
INDIANAPOLIS, Oct. 25, 2024 /PRNewswire/ -- Calumet, Inc. (NASDAQ:CLMT) (the "Company," "Calumet," "we," "our" or "us"), announced today that it plans to report results for the Third Quarter 2024 on November 8, 2024. A conference call to discuss the financial and operational results is scheduled for November 8th at 9:00 AM ET. Investors, analysts and members of the media interested in listening to the live presentation are encouraged to join a webcast of the call with accompanying presentation slides; parties interested in listening to the webcast may follow the link which will be made available at http://calumetspecialty.investorroom.com/events. For those participants wishing to dial into
8-K - Calumet, Inc. /DE (0002013745) (Filer)
8-K - Calumet, Inc. /DE (0002013745) (Filer)
8-K - Calumet, Inc. /DE (0002013745) (Filer)
TD Cowen reiterated coverage of Calumet Specialty Products with a rating of Buy and set a new price target of $26.00 from $27.00 previously
TD Cowen reiterated coverage of Calumet Specialty Products with a rating of Buy and set a new price target of $27.00 from $22.00 previously
TD Cowen reiterated coverage of Calumet Specialty Products with a rating of Buy and set a new price target of $18.00 from $20.00 previously
4 - Calumet, Inc. /DE (0002013745) (Issuer)
4 - Calumet, Inc. /DE (0002013745) (Issuer)
4 - Calumet, Inc. /DE (0002013745) (Issuer)